Perturbing the Normal Level of SIDT1 Suppresses the Naked ASO Effect
Although antisense oligonucleotide (ASO) therapeutics can be taken up by living cells without carrier molecules, a large part of incorporated ASOs are trapped in the endosomes and do not exert therapeutic effects. To improve their therapeutic effects, it would be important to elucidate the mechanism...
Saved in:
Main Authors: | Masayuki Takahashi, Mineaki Seki, Masayuki Nashimoto, Tomohiro Kabuta |
---|---|
Format: | article |
Language: | EN |
Published: |
Hindawi Limited
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/6bbd43e111d942ffb5f9e3594e13f4dc |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DNAzymes, Novel Therapeutic Agents in Cancer Therapy: A Review of Concepts to Applications
by: I. B. K. Thomas, et al.
Published: (2021) -
Trans-tail regulation-mediated suppression of cryptic transcription
by: Jungmin Choi, et al.
Published: (2021) -
Epigenetic modulation of selected immune response genes and altered functions of T lymphocytes and macrophages collectively contribute to autoimmune diabetes protection
by: Arathi Jayaraman, et al.
Published: (2021) -
Editor'den [Editorial] 30. Yilimizi Kutluyoruz [We are celebrating the 30th Anniversary]
by: N. Leyla Acan, et al.
Published: (2006) -
The insulin centennial—100 years of milestones in biochemistry
by: Alan D. Attie, et al.
Published: (2021)